United States Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: December 31, 2025 Report Code: GDME26634CCDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “United States Glucose Monitoring Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Glucose Monitoring market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments –

The United States Glucose Monitoring Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Glucose Monitoring Market.
• Global corporate-level profiles of key companies operating within the United States Glucose Monitoring Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Glucose Monitoring is segmented as follows –

• Continuous Glucose Monitors

Reasons to Buy

The United States Glucose Monitoring Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Abbott Laboratories_x000D_
DexCom Inc_x000D_
Medtronic Plc

1 Table of Contents

2 Introduction_x000D_

2.1 What Is This Report About?_x000D_

2.2 Glucose Monitoring Market Segmentation_x000D_

2.3 Definitions of Markets Covered in the Report_x000D_

3 Glucose Monitoring Market, United States_x000D_

3.1 Glucose Monitoring Market, United States, Revenue ($m), 2018-2033_x000D_

3.1.1 Continuous Glucose Monitors Market, United States, Revenue ($m), by Segment, 2018-2033_x000D_

3.2 Glucose Monitoring Market, United States, Volume (Units), 2018-2033_x000D_

3.2.1 Continuous Glucose Monitors Market, United States, Volume (Units), by Segment, 2018-2033_x000D_

3.3 Glucose Monitoring Market, United States, Average Price ($), 2018-2033_x000D_

3.4 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2025_x000D_

4 Overview of Key Companies in United States, Glucose Monitoring Market_x000D_

4.1 Abbott Laboratories_x000D_

4.1.1 Company Overview_x000D_

4.2 DexCom Inc_x000D_

4.2.1 Company Overview_x000D_

4.3 Medtronic Plc_x000D_

4.3.1 Company Overview_x000D_

5 Glucose Monitoring Market Pipeline Products_x000D_

6 Recent Developments_x000D_

6.1 Corporate Communications_x000D_

6.1.1 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work_x000D_

6.1.2 Nov 18, 2025: Dedicated Platelet Donor Discovers Health Benefits of A1C Testing_x000D_

6.1.3 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors_x000D_

6.1.4 Oct 29, 2025: Glucotrack Appoints Usman Latif, MD, MBA, to Clinical Advisory Team_x000D_

6.1.5 Oct 17, 2025: USF Health Leads Collaborative Effort to Enhance Type 1 Diabetes Prediction, Prevention, and Treatment_x000D_

6.1.6 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed_x000D_

6.1.7 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio_x000D_

6.1.8 Apr 23, 2025: Biolinq raises $100m to support US launch of intradermal glucose sensor_x000D_

6.1.9 Feb 19, 2025: Thermo Fisher Scientific Elects New Director to Board_x000D_

6.1.10 Jan 21, 2025: Glucotrack Announces ISO 13485:2016 Certification_x000D_

6.2 Financial Announcements_x000D_

6.2.1 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results_x000D_

6.2.2 Oct 22, 2025: Senseonics Holdings Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time_x000D_

6.2.3 Oct 06, 2025: Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update_x000D_

6.2.4 Aug 06, 2025: Senseonics Holdings Announces Results for Q2 Ended June 30, 2025_x000D_

6.2.5 Jul 01, 2025: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 23, 2025_x000D_

6.2.6 Apr 15, 2025: Johnson & Johnson Announces Q1 2025 Results_x000D_

6.2.7 Mar 03, 2025: Senseonics Holdings Reports Fourth Quarter and Full Year 2024 Financial Results_x000D_

6.2.8 Jan 02, 2025: Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025_x000D_

6.3 Government and Public Interest_x000D_

6.3.1 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference_x000D_

6.3.2 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract_x000D_

6.3.3 Apr 16, 2025: Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference_x000D_

6.3.4 Feb 24, 2025: Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025_x000D_

6.3.5 Feb 03, 2025: Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference_x000D_

6.3.6 Jan 07, 2025: New Publication Highlights Safety and Potential Benefits of Redosing Diamyd Precision Medicine for Type 1 Diabetes_x000D_

6.3.7 Dec 17, 2024: Double Medical Technology Receives 510(K) Clearance For Locking Screw CoCrMo_x000D_

6.3.8 Dec 12, 2024: Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference_x000D_

6.4 Other Significant Developments_x000D_

6.4.1 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results_x000D_

6.4.2 Oct 27, 2025: Lifescan Receives Court Approval of Plan of Reorganization_x000D_

6.4.3 Oct 22, 2025: Dong-A ST Signs Sales Agreement for CareSens Air with i-SENS_x000D_

6.4.4 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)_x000D_

6.4.5 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program_x000D_

6.4.6 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes_x000D_

6.5 Product News_x000D_

6.5.1 Nov 20, 2025: Stanley Hsia, MD, Presents Phase 2 Trial Results for Mazdutide_x000D_

6.5.2 Nov 13, 2025: Century Therapeutics Unveils Beta Islet Program for Type 1 Diabetes_x000D_

6.5.3 Nov 10, 2025: Scientists Identify Trigger for Obesity-Linked Inflammation_x000D_

6.5.4 Nov 10, 2025: Senseonics Holdings To Participate in the Stifel 2025 Healthcare Conference_x000D_

6.5.5 Nov 06, 2025: Quebec Expands Access to Dexcom Continuous Glucose Monitoring Systems_x000D_

6.5.6 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results_x000D_

6.5.7 Oct 30, 2025: Profusa Outlines Path to $250 Million Revenue by 2030 Driven by Lumee Oxygen and Glucose Monitoring Launches_x000D_

6.5.8 Oct 14, 2025: OSR Holdings Enters Agreement to Acquire Woori IO for Noninvasive Glucose Monitoring Technology_x000D_

6.5.9 Oct 13, 2025: MannKind Receives FDA Acceptance for Afrezza Application for Pediatric Diabetes Treatment_x000D_

6.5.10 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment_x000D_

6.5.11 Oct 03, 2025: Hong Kong Grants Precision Medicine Patent to Diamyd Medical for Insulin Antigen Treatment in Type 1 Diabetes_x000D_

6.5.12 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes_x000D_

6.5.13 Jul 10, 2025: Wristband Sensor Provides All-in-one Monitoring for Diabetes and Cardiovascular Care_x000D_

6.5.14 Apr 28, 2025: Thermo Fisher Scientific Leverages Integrated Solutions To Accelerate the Development of Biologic Therapeutics_x000D_

6.5.15 Mar 03, 2025: High School Junior Max Kopp is Pioneering the Future of Wearable Technology, Championed by Crown Wealth_x000D_

6.5.16 Jan 06, 2025: Introducing isaac by PreEvnt – Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit_x000D_

6.6 Strategy And Business Planning_x000D_

6.6.1 Nov 06, 2025: Quebec Expands Access to Dexcom Continuous Glucose Monitoring Systems_x000D_

6.6.2 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results_x000D_

6.6.3 Oct 30, 2025: Profusa Outlines Path to $250 Million Revenue by 2030 Driven by Lumee Oxygen and Glucose Monitoring Launches_x000D_

6.6.4 Oct 22, 2025: Dong-A ST Signs Sales Agreement for CareSens Air with i-SENS_x000D_

6.6.5 Oct 17, 2025: USF Health Leads Collaborative Effort to Enhance Type 1 Diabetes Prediction, Prevention, and Treatment_x000D_

6.6.6 Oct 16, 2025: Thermo Fisher Scientific To Accelerate Life Science Breakthroughs With OpenAI_x000D_

6.6.7 Sep 23, 2025: Glooko Acquires Monarch Medical Technologies to Broaden Diabetes Care Solutions_x000D_

6.6.8 Sep 17, 2025: Hackensack Meridian Health Launches Your Health On The Move Initiative for Free Health Screenings in New Jersey_x000D_

6.6.9 May 19, 2025: Actinogen CMO Presents Positive Depression Trial Data at the American Psychiatric Association 2025 Annual Meeting_x000D_

7 Appendix_x000D_

7.1 Research Methodology_x000D_

7.1.1 Coverage_x000D_

7.1.2 Secondary Research_x000D_

7.1.3 Primary Research_x000D_

7.1.4 Market Modeling and Forecasting_x000D_

7.1.5 Company Share Analysis_x000D_

7.1.6 Benchmarking_x000D_

7.2 GlobalData Consulting_x000D_

7.3 Contact Us_x000D_

7.4 Disclaimer

Table

Table 1: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 2: Continuous Glucose Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Table 3: Glucose Monitoring Market, United States, Volume (Units), 2018-2033_x000D_

Table 4: Continuous Glucose Monitors Market, United States, Volume (Units), 2018-2033_x000D_

Table 5: Glucose Monitoring Market, United States, Average Price ($), 2018-2033_x000D_

Table 6: Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2025_x000D_

Table 7: Glucose Monitoring Market Pipeline Products

Figures

Figure 1: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 2: Continuous Glucose Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033_x000D_

Figure 3: Glucose Monitoring Market, United States, Volume (Units), 2018-2033_x000D_

Figure 4: Continuous Glucose Monitors Market, United States, Volume (Units), 2018-2033_x000D_

Figure 5: Glucose Monitoring Market, United States, Company Share (%), 2025

United States Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Diabetes Care Devices reports

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Medical Devices

New

Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors in real time.

Access a live United States Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

United States Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports